Atomoxetine for genetic obesity due to MC4R changes
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests a medicine called atomoxetine (Strattera) to help people with a specific genetic form of obesity lose weight. It may be an option if you have a change in the MC4R gene and have not used certain other medications recently.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 6 years old or older.
- You have a specific change in the MC4R gene linked to obesity (confirmed by a standard lab test).
- You have obesity (BMI 30 or higher for adults, or at the 95th percentile or above for children).
- You have not taken stimulant medications or atomoxetine in the past 30 days.
- You have not lost more than 5% of your body weight in the last 3 months.
- You do not have certain serious health issues like uncontrolled high blood pressure, heart rhythm problems, or severe depression.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a drug called setmelanotide for people with Bardet-Biedl Syndrome (a rare genetic condition) or other severe genetic obesity. It looks at how well the drug works in real-world settings, not just in a lab.
This study tests a new medicine called PF-08653945 to see how it enters the blood in adults who are overweight or have obesity. The results will help doctors understand how the medicine works in the body.
This study tests a new medicine called RM-718 for people with severe obesity linked to a specific brain pathway (MC4R). It may help if your obesity is due to a brain injury or tumor affecting the hypothalamus, or if you have Prader-Willi syndrome.
This trial tests if a special test can help pick the best weight-loss medicine for you. It is for Mayo Clinic employees or their dependents who are in a weight management program.
This study tests an investigational medication called MBX 4291 for adults with obesity. It aims to see if the drug is safe and how it works in the body, which could lead to a new weight-loss treatment option.
This study tests whether atomoxetine, a medication that affects brain chemicals, can boost motivation in healthy adults. If you join, you'll be helping researchers understand the drug's effects and whether it might help with conditions that affect motivation.
Hear when a new Melanocortin Obesity Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.